Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.

Slides:



Advertisements
Similar presentations
Purpose of A.S.T.H.M.A. Quality improvement initiative to enhance the care for individuals with asthma in Alberta by: – identifying barriers to optimal.
Advertisements

What's New in Basal Insulin for Diabetes
Persuasive Messages Module Twelve McGraw-Hill/Irwin
Short-, Intermediate-, Long-Acting Insulins
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
BACK SOLUTION:
Why Gene Therapy for Hemophilia?
Special Consideration in Insulin Therapy
New Patient-Friendly Options for Managing Insulin Dosing
Overview of Disparities
Modern Strategies for Basal Insulin Use in T2D
Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.
The Comprehensive Major Depressive Disorder Care Team
Insulin/GLP-1 Agonist Combinations
Obesity and Dyslipidemia: How Would You Treat?
Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.
Patient-Centered Care in Cystic Fibrosis
How Early Should Basal Insulin Be Used in T2D Management?
Working as a Team for Improved Patient Outcomes in Type 2 Diabetes
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
What Would You Do in This Case of MDD?
Emerging Basal Insulins for Diabetes
Insights into Insulin Treatment Challenges: Real-World Evidence and Clinical Trial Data.
HBV Care Models: Community Collaborations for Best Practices
Follow-Up of the Patient After PE
Introduction. Family Planning and Pregnancy Management in Patients With Chronic Inflammatory Rheumatic Diseases.
Talking to Patients About Diabetes Management
Learning outcome 4 – Evaluating impact of technology
Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Insulin/GLP-1 Agonist Combinations
Insulin Use in Primary Care: Practice Challenges
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
The Importance of Getting the Dose Right in HF
Simplifying Insulin Delivery for Better Patient Outcomes in T2D
Predictive Low Glucose Suspend (PLGS)
The Primary Care Guide to New CGM Devices and the AGP
Managing Polycythemia Vera in the Community Setting
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Providing Hope and Opportunity
Better Diabetes Control With Novel Basal Insulins
Student Names School Name Teacher’s Name Date
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.
Managing HF in Primary Care
Advancements in Glucose Monitoring
Student Names School Name Teacher’s Name Date
Insulin in Diabetes Management: Effective Patient Selection Is Key
Providers’ Views Are Mixed on Impact of Medical Homes, with Those Working in Medical Homes More Positive Do you think the increased use of medical homes.
Peer Pressure The influence exerted by a peer group encouraging a person to change his or her attitudes, values, or behavior in order to conform to group.
Overview. Overview Context Context scope Provider supply.
Improving Effective Basal Insulin Use in Clinical Practice
A Multidisciplinary Perspective on the Management of Hypoparathyroidism.
Navigating New Treatment Landscapes in HR+ HER2-Negative Advanced Breast Cancer.
In persuasive messages, you want the reader to act upon your message
Midterm Thanks for coming in….
Emerging Combination Injectable Therapy A New Era in Diabetes Care
Action/Solution Poster
Managing HF in Primary Care
Fixed-Ratio Combination Therapy in T2DM
Physician Mailing Lists
New Advances in Hybrid Closed-Loop Control of Insulin Therapy
Customer Problem Statement Template
Emerging Basal Insulins for Diabetes
Fresh perspectives ON BASAL Insulins in diabetes care
The Challenge of Insulin Titration
Presentation transcript:

Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting

Introduction to Basal Insulin Therapy in T2D

Reluctance to Initiate Insulin Therapy

How Common is the Delay in Initiation of Insulin?

Obstacles to Initiation of Insulin Therapy

6 Obstacles to Initiation of Insulin Therapy

Why Such Negative Attitudes?

Physician Influences

Physician Resistance to Initiation

Key Findings From the DAWN and MOSAIc Studies

Identifying Solutions to PIR The EMOTION Study

5 Key HCP Action Themes

Impact of HCP Action Themes

3 Practical Solutions For Addressing PIR

Abbreviations